Will the cumulative global market valuation of companies specializing in 'Neurotechnology as a Service' (NaaS) exceed $100 billion before the end of 2028?

Neurotech Market: NaaS Valuation Hits $100 Billion by 2028

Neurotechnology as a Service (NaaS) refers to the commercialization of software and subscription services built around Brain-Computer Interfaces (BCI), ranging from medical applications (prosthetics control) to consumer wellness (focus tracking, meditation). This prediction states that the cumulative global market valuation of companies specializing in NaaS will exceed $100 billion before the end of 2028.

Medical and Wellness Demand

The majority 'Yes' vote is driven by the vast, untapped market potential of BCI. Key factors include:

• **Medical Breakthroughs:** Regulatory approval for groundbreaking invasive BCI solutions (e.g., Neuralink, Synchron) for treating paralysis and neurological disorders, generating massive initial value.
• **Consumer Wellness:** Mass market adoption of non-invasive BCI wearables for mental fitness, gaming, and productivity, leveraging subscription models.
• **Venture Capital:** Sustained, high-value investment rounds pouring into specialized NaaS startups.

The $100 billion figure signifies a major commercialization inflection point for a technology previously confined to research labs.